SMN1 and neoplasm: Low or high expression of α-smooth muscle actin (SMA) is a consistent differential feature of CAF subtypes; “myofibroblastic” CAFs (myCAFs) express high levels of SMA, are juxtaposed or in close proximity to cancer cells, and exhibit tumor-restraining function [93–99].